ZECHENG ELECTRONICS
837821
Ji Yao Holding Group
300108
Shenzhen Bestek Technology
300822
Jiangsu Canlon Building Materials
300715
Shanghai Hajime Advanced Material Technology
301000
CN Stock MarketDetailed Quotes
000597 Northeast Pharmaceutical Group
- 5.27
- -0.23-4.18%
Market Closed Jan 9 15:00 CST
7.53BMarket Cap21.69P/E (TTM)
5.41High5.26Low527.52KlotVolume5.40Open5.50Pre Close280.61MTurnover3.76%Turnover Ratio21.00P/E (Static)1.43BShares6.6952wk High1.46P/B7.39BFloat Cap3.6752wk Low6.05Limit Up1.40BShs Float12.84Historical High4.95Limit Down2.73%Amplitude0.69Historical Low0.10Dividend TTM5.32Avg Price332.93KlotAsk1.90%Div YieldTTM100Lot Size189.95KlotBid
Northeast Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -5.94%5.88B | -11.87%3.73B | -20.39%1.7B | -5.50%8.48B | -3.31%6.25B | 2.17%4.24B | 8.72%2.13B | 4.93%8.97B | 7.29%6.46B | 6.35%4.15B |
| Refunds of taxes and levies | 90.37%16.46M | 186.04%14.78M | 642.38%9.22M | -75.05%9.9M | -59.44%8.65M | -68.61%5.17M | -87.99%1.24M | 16.43%39.67M | -22.83%21.32M | 4.16%16.46M |
| Cash received relating to other operating activities | -32.50%223.85M | -33.66%190.65M | -24.16%88.23M | 49.35%407.15M | 80.37%331.64M | 113.50%287.39M | 26.15%116.34M | 28.08%272.61M | 28.99%183.86M | 17.81%134.61M |
| Cash inflows from operating activities | -7.15%6.12B | -13.03%3.94B | -20.22%1.8B | -4.19%8.89B | -1.18%6.59B | 5.39%4.53B | 9.01%2.25B | 5.53%9.28B | 7.66%6.67B | 6.66%4.3B |
| Goods services cash paid | 2.26%3.53B | -5.44%2.15B | -14.08%999.22M | -0.38%4.78B | -2.22%3.46B | 2.53%2.27B | 8.55%1.16B | 3.35%4.8B | 10.88%3.54B | 7.74%2.21B |
| Staff behalf paid | 2.29%791.02M | 6.71%591.52M | 20.95%357.91M | 0.51%1.02B | -0.14%773.28M | 2.64%554.31M | 7.32%295.93M | -6.10%1.02B | -9.22%774.36M | -12.30%540.04M |
| All taxes paid | -10.52%401.24M | -17.54%268.91M | -9.02%130.7M | 19.18%545.56M | 39.54%448.42M | 52.76%326.13M | 27.12%143.67M | 2.09%457.76M | -11.43%321.36M | -10.51%213.49M |
| Cash paid relating to other operating activities | -39.28%962M | -48.20%575.81M | -60.11%212.88M | 3.07%1.96B | 16.16%1.58B | 26.03%1.11B | 56.04%533.67M | 1.37%1.9B | 1.12%1.36B | -6.47%882.07M |
| Cash outflows from operating activities | -9.16%5.69B | -15.94%3.58B | -20.39%1.7B | 1.63%8.31B | 4.47%6.26B | 10.72%4.26B | 18.54%2.14B | 1.55%8.17B | 4.20%5.99B | -0.07%3.85B |
| Net cash flows from operating activities | 31.42%428.57M | 33.65%354.84M | -17.02%94.89M | -47.07%586.75M | -51.52%326.1M | -40.55%265.51M | -56.42%114.35M | 48.50%1.11B | 52.81%672.68M | 154.53%446.62M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -95.06%368.99K | -95.06%368.99K | -94.92%377.32K | 179.15%7.47M | 825.76%7.47M | 1,791.43%7.47M | 2,150.61%7.43M | -30.25%2.67M | -88.95%806.58K | -91.13%394.78K |
| Cash inflows from investing activities | -95.06%368.99K | -95.06%368.99K | -94.92%377.32K | 179.15%7.47M | 825.76%7.47M | 1,791.43%7.47M | 2,150.61%7.43M | -99.49%2.67M | -88.95%806.58K | -91.13%394.78K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -22.72%136.1M | -12.05%92.66M | 38.38%50.24M | -3.56%235.43M | 0.18%176.12M | 0.12%105.35M | -51.78%36.31M | 103.77%244.13M | 100.25%175.8M | 66.49%105.23M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.02%14.89M | --0 | ---- |
| Cash outflows from investing activities | -22.72%136.1M | -12.05%92.66M | 38.38%50.24M | -9.11%235.43M | 0.18%176.12M | 0.12%105.35M | -51.78%36.31M | -58.21%259.02M | -70.09%175.8M | -81.32%105.23M |
| Net cash flows from investing activities | 19.52%-135.73M | 5.71%-92.29M | -72.66%-49.86M | 11.07%-227.96M | 3.62%-168.65M | 6.63%-97.88M | 61.47%-28.88M | -156.15%-256.34M | 69.85%-174.99M | 81.24%-104.83M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5,781.98%235.28M | 6,843.37%208.3M | --500K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -87.50%500K | -83.33%500K | --500K |
| Cash from borrowing | -40.56%1.46B | -39.03%707.2M | 24.49%560.2M | -9.54%2.76B | 6.91%2.46B | -32.60%1.16B | -48.22%450M | -21.30%3.05B | -27.42%2.3B | -31.36%1.72B |
| Cash received relating to other financing activities | 30.19%9.54B | 50.45%7.09B | -25.19%1.61B | 100.42%11.22B | 95.15%7.33B | 77.70%4.71B | 99.02%2.15B | 98.61%5.6B | 62.17%3.76B | 45.44%2.65B |
| Cash inflows from financing activities | 12.41%11B | 32.78%7.8B | -16.59%2.17B | 57.35%13.98B | 56.25%9.79B | 34.29%5.87B | 33.35%2.6B | 32.61%8.88B | 14.13%6.27B | 1.00%4.37B |
| Borrowing repayment | -29.23%1.54B | -51.15%606.03M | 73.27%350M | -15.70%2.83B | 9.68%2.17B | -8.68%1.24B | -79.02%202M | -17.38%3.36B | -18.14%1.98B | -30.95%1.36B |
| Dividend interest payment | -16.42%194.32M | -13.57%178.93M | -31.03%17.9M | 100.79%219.78M | 102.13%232.48M | 134.97%207.02M | -19.15%25.95M | -33.87%109.46M | -11.48%115.01M | -10.42%88.1M |
| -Including:Cash payments for dividends or profit to minority shareholders | -95.30%45.49K | ---- | ---- | ---- | --967.79K | --597.61K | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 47.91%9.66B | 47.99%6.91B | -21.76%1.6B | 92.58%10.55B | 86.92%6.53B | 75.52%4.67B | 88.67%2.05B | 110.33%5.48B | 40.45%3.49B | 35.02%2.66B |
| Cash outflows from financing activities | 27.50%11.39B | 25.79%7.69B | -13.42%1.97B | 52.05%13.6B | 59.88%8.93B | 48.94%6.11B | 9.35%2.27B | 30.91%8.94B | 10.98%5.59B | 1.75%4.11B |
| Net cash flows from financing activities | -145.09%-385.86M | 145.23%108.58M | -38.63%200.7M | 746.08%381.1M | 26.36%855.75M | -189.22%-240.07M | 353.70%327M | 55.45%-58.99M | 49.10%677.22M | -9.22%269.09M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -190.94%-8.47M | -68.72%2.78M | 160.75%1.43M | -8.94%6.29M | 0.60%9.31M | 256.21%8.88M | -1,640.36%-2.36M | 511.55%6.91M | 1,175.38%9.26M | 296.62%2.49M |
| Net increase in cash and cash equivalents | -109.93%-101.49M | 688.29%373.91M | -39.74%247.15M | -6.75%746.18M | -13.65%1.02B | -110.36%-63.56M | 602.43%410.11M | 56.17%800.16M | 278.25%1.18B | 795.99%613.37M |
| Add:Begin period cash and cash equivalents | 36.93%2.77B | 36.93%2.77B | 36.93%2.77B | 65.55%2.02B | 65.55%2.02B | 65.55%2.02B | 65.55%2.02B | 72.34%1.22B | 72.34%1.22B | 72.34%1.22B |
| End period cash equivalent | -12.41%2.67B | 60.48%3.14B | 23.99%3.01B | 36.93%2.77B | 26.55%3.04B | 6.72%1.96B | 90.06%2.43B | 65.55%2.02B | 135.46%2.4B | 195.74%1.83B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
